Trade Mark Journal No.2025/044 31 October 2025
WO0000001881523 (1,5,40)
Office of origin: United States of America
Date of International Registration:26 August 2025
Date of designation in the UK:
26 August 2025
International priority date claimed: 26 February 2025
(United States of America)
(99057963)
- Class 1
- Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for use in scientific and medical research in connection with appetite control, body weight management, metabolism, cardiovascular and renal diseases, neurological and neurodegenerative diseases, brain health, substance use disorder, pain, neuropsychiatry, inflammation, and immunology; biomedical compounds, namely, peptide substrates used in analyzing and detecting toxins for research purposes.
- Class 5
- Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for use in connection with medical treatment of appetite control, body weight management, metabolism, cardiovascular and renal diseases, neurological and neurodegenerative diseases, brain health, substance use disorder, pain, neuropsychiatry, inflammation, and immunology; biomedical compounds, namely, peptide substrates used in analyzing and detecting toxins for medical purposes.
- Class 40
- Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use; custom manufacturing of synthetic proteins and peptides.
Abiologics, Inc.
Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA